RANGE AT RHEUMATOID ARTHRITIS AGAINST THERAPY THE RITUKSIMABY
The main aim of our research was to study the dynamics of indexes of lipid profile from patients with rheumatoid arthritis during 52 weeks. We have found that the therapy with rituximab in combination with me- totrexate brings the reduction of clinic and immunological activities, improvement of func...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
North Caucasus Federal University
2022-05-01
|
| Series: | Вестник Северо-Кавказского федерального университета |
| Subjects: | |
| Online Access: | https://vestnikskfu.elpub.ru/jour/article/view/2040 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|